This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
This symposium will particularly focus on translation medicine, and will be featuring speakers talking about gene editing, including those from Editas, Crispr Tx, Intellia and researchers from universities.
The main purpose of the International Mammalian Genome Society is to promote and stimulate research in mammalian genetics from sequencing to functional genomics, mutagenesis and mutant analysis, and to represent the concerns of its members in their professional activities. The company's activities have grown with the growing awareness of the important and unique role of rodent species in biomedical research and current genetics.